Insider · CIK 0001810406

Bjork Elisabeth

Reports to the SEC for 2 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001810406

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-17	PHVSPharvaris N.V.M Exercise/Conversion	Director	MExercise/Conversion	+35K sh	$14.39	+$504K	50,167
2026-09-17	PHVSPharvaris N.V. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.5K sh	—	—	0
2026-09-17	PHVSPharvaris N.V. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−35K sh	—	—	0
2026-09-17	PHVSPharvaris N.V.S Sale	Director	SSale	−52.5K sh	$37.89	−$1.99M	15,167
2026-09-17	PHVSPharvaris N.V.M Exercise/Conversion	Director	MExercise/Conversion	+17.5K sh	$18.14	+$317K	67,667
2026-05-20	PHVSPharvaris N.V. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	11,000
2026-05-20	PHVSPharvaris N.V.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$8.05	+$80.5K	25,167
2026-05-20	PHVSPharvaris N.V.S Sale	Director	SSale	−10K sh	$29.32	−$293K	15,167
2026-01-02	RCKTROCKET PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+10K sh	$3.44	+$34.4K	50,000
2025-08-27	RCKTROCKET PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+10K sh	$3.41	+$34.1K	40,000
2025-06-18	RCKTROCKET PHARMACEUTICALS, INC.A Award	Director	AAward	+30K sh	—	—	30,000
2024-09-26	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+607 sh	—	—	607
2024-06-13	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,325 sh	$15.04	+$50K	3,325
2024-06-13	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+23.9K sh	—	—	23,944
2023-06-22	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+25.9K sh	—	—	25,850
2023-06-22	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,590 sh	$13.93	+$50K	3,590
2022-06-13	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,345 sh	$6.80	+$49.9K	7,345
2022-06-13	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+47.7K sh	—	—	47,745
2021-06-14	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,699 sh	$29.42	+$50K	1,699
2021-06-14	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,236
2020-06-16	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-04-20	RCKTROCKET PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Sep 214
Bjork Elisabeth0001193125-26-396584
SEC(opens sec.gov)
May 224
Bjork Elisabeth0001193125-26-236432
SEC(opens sec.gov)
Jan 64
Bjork Elisabeth0001140361-26-000378
SEC(opens sec.gov)
Aug 274
Bjork Elisabeth0001140361-25-033017
SEC(opens sec.gov)
Jul 184
Bjork Elisabeth0001140361-25-026405
SEC(opens sec.gov)
Oct 294
Bjork Elisabeth0001140361-24-044548
SEC(opens sec.gov)
Jun 204
Bjork Elisabeth0001140361-24-030731
SEC(opens sec.gov)
Jun 264
Bjork Elisabeth0001140361-23-031526
SEC(opens sec.gov)
Jun 154
Bjork Elisabeth0001140361-22-023149
SEC(opens sec.gov)
Jun 164
Bjork Elisabeth0001140361-21-021291
SEC(opens sec.gov)

Companies

Address

1 CRANBERRY HILL SUITE 400

LEXINGTON, MA, 02421